Up-regulation of niacinamide in intervertebral disc aggrecan in vitro

Xiaoqian Xiong1, Shuhua Yang, Zengwu Shao

  • 1Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Insights

Niacinamide (Nia) shows potential in treating intervertebral disc (IVD) degeneration. This study found Nia increased aggrecan expression and protected IVDs from damage in vitro, suggesting a possible clinical therapy.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Regenerative Medicine

Background:

  • Intervertebral disc (IVD) degeneration is a significant cause of back pain.
  • Interleukin-1 (IL-1) is a key mediator in IVD degeneration.
  • Aggrecan is a crucial proteoglycan for IVD structure and function.

Purpose of the Study:

  • To investigate the regulatory effects of niacinamide (Nia) on IVD aggrecan expression in vitro.
  • To evaluate Nia's protective effects against IL-1-induced IVD degeneration.

Main Methods:

  • Established a rabbit IVD degeneration model induced by IL-1.
  • Treated normal and degenerated IVDs with varying concentrations of Nia (0.05, 0.25, 0.5 mg/mL).
  • Assessed glycosaminoglycan (GS) content, safranin O-fast green staining intensity, and aggrecan core protein gene expression via RT-PCR.

Main Results:

  • Nia treatment significantly increased GS content in nucleus pulposus (NP) and fibrous rings, with dose-dependent effects.
  • Safranin O-fast green staining indicated increased matrix density and alleviated histological damage in Nia-treated IVDs.
  • RT-PCR confirmed that Nia upregulated aggrecan core protein gene expression in IL-1-induced degenerated IVDs.

Conclusions:

  • Niacinamide upregulates aggrecan expression in intervertebral discs.
  • Nia demonstrates protective effects against IL-1-induced IVD degeneration in vitro.
  • Nia represents a potential therapeutic agent for clinical management of IVD degeneration.

Related Concept Videos

Degenerative Disc Disease I: Introduction01:27

Degenerative Disc Disease I: Introduction

Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...
Degenerative Disc Disease ll: Pathophysiology01:23

Degenerative Disc Disease ll: Pathophysiology

The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...
Herniated Intervertebral Disc l: Introduction01:29

Herniated Intervertebral Disc l: Introduction

Intervertebral disc herniation refers to the displacement of the nucleus pulposus (the gel-like inner core of the disc) through a tear or weakened area in the annulus fibrosus (the outer fibrous ring). The displaced disc material extends beyond the normal boundaries of the disc space and may compress or irritate nearby spinal nerve roots or, less commonly, the spinal cord.Etiology and Risk FactorsHerniation commonly results from degeneration, in which aging reduces disc hydration and...
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...